PIKFYVE and infection: PIKfyve inhibitor treatment was initiated in triplicate at 2 h pre-infection, at the time of infection, or 2- or 6-h post-infection with SARS-CoV-2 (WA-1), and supernatants were collected after 24 h to assess virus output by plaque assay (Fig. 1).